High CHI3L1 immune reactivity is associated with poor prognosis in endometrial cancer patients, and CHI3L1 also plays a role in angiogenesis and primary and metastatic tumors around tumor blood vessels [151]. Here, CHI3L1 is linked to endometrial cancer.